Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation

Journal of Neuroimmune Pharmacology

Volumn 10, Issue 3, 2015, Pages 468-476

  Báez Pagán, Carlos A ^a   Delgado Vélez, Manuel ^a   Lasalde Dominicci, José A ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Alpha7 nAChR; Cholinergic anti inflammatory pathway; Inflammation; Monocyte derived macrophages (MDMs); Nicotinic acetylcholine receptor

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BUNGAROTOXIN RECEPTOR; CHOLINE ACETYLTRANSFERASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NICOTINIC RECEPTOR; NORADRENALIN; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; STAT3 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; CELIAC PLEXUS; CELL ATTACHED PATCH CLAMP; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE ACTIVATION; NORMAL HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA; VAGUS NERVE; IMMUNOLOGY; MACROPHAGE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; HUMANS; INFLAMMATION; JANUS KINASE 2; MACROPHAGE ACTIVATION; MACROPHAGES; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VAGUS NERVE;

EID: 84939522882     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-015-9601-5     Document Type: Article

References (51)

1. Alkondon M, Pereira EF, Cortes WS et al (1997) Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci 9:2734–2742
2. Arias HR (1998) Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim Biophys Acta 1376:173–220
3. Benfante R, Antonini RA, De Pizzol M et al (2011) Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS. J Neuroimmunol 230:74–84. doi:10.1016/j.jneuroim.2010.09.008
4. Borovikova LV, Ivanova S, Zhang M et al (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–462. doi:10.1038/35013070
5. Brown KC, Lau JK, Dom AM et al (2012) MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway. Angiogenesis 15:99–114. doi:10.1007/s10456-011-9246-9
6. Cartaud J, Cartaud A, Kordeli E et al (2000) The torpedo electrocyte: a model system to study membrane-cytoskeleton interactions at the postsynaptic membrane. Microsc Res Tech 49:73–83. doi:10.1002/(SICI)1097-0029(20000401)49:1<73::AID-JEMT8>3.0.CO;2-L
7. Changeux JP, Edelstein SJ (1998) Allosteric receptors after 30 years. Neuron 21:959–980
8. Changeux JP, Devillers-Thiéry A, Galzi JL, Bertrand D (1992) New mutants to explore nicotinic receptor functions. Trends Pharmacol Sci 13:299–301
9. Charpantier E, Wiesner A, Huh K-H et al (2005) Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. J Neurosci 25:9836–9849. doi:10.1523/JNEUROSCI. 3497-05.2005
10. Cockcroft VB, Osguthorpe DJ, Barnard EA et al (1990) Ligand-gated ion channels. Homology and diversity. Mol Neurobiol 4:129–169. doi:10.1007/BF02780338
11. Cooper E, Couturier S, Ballivet M (1991) Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350:235–238. doi:10.1038/350235a0
12. Corringer PJ, Le Novère N, Changeux JP (2000) Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 40:431–458. doi:10.1146/annurev.pharmtox.40.1.431
13. daCosta CJB, Free CR, Corradi J et al (2011) Single-channel and structural foundations of neuronal α7 acetylcholine receptor potentiation. J Neurosci 31:13870–13879. doi:10.1523/JNEUROSCI. 2652-11.2011
14. De Jonge WJ, van der Zanden EP, The FO et al (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6:844–851. doi:10.1038/ni1229
15. De Lucas-Cerrillo AM, Maldifassi MC, Arnalich F et al (2011) Function of partially duplicated human α77 nicotinic receptor subunit CHRFAM7A gene: potential implications for the cholinergic anti-inflammatory response. J Biol Chem 286:594–606. doi:10.1074/jbc.M110.180067
16. Delgado-Vélez M, Lugo-Chinchilla A, Lizardo L et al (2008) Chronic exposure of human macrophages in vitro to morphine and methadone induces a putative tolerant/dependent state. J Neuroimmunol 196:94–100. doi:10.1016/j.jneuroim.2008.03.004
17. Devillers-Thiéry A, Galzi JL, Eiselé JL et al (1993) Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels. J Membr Biol 136:97–112
18. DiPaola M, Czajkowski C, Karlin A (1989) The sidedness of the COOH terminus of the acetylcholine receptor delta subunit. J Biol Chem 264:15457–15463
19. Galzi JL, Revah F, Bessis A, Changeux JP (1991) Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain. Annu Rev Pharmacol Toxicol 31:37–72. doi:10.1146/annurev.pa.31.040191.000345
20. Gilbert D, Lecchi M, Arnaudeau S et al (2009) Local and global calcium signals associated with the opening of neuronal alpha7 nicotinic acetylcholine receptors. Cell Calcium 45:198–207. doi:10.1016/j.ceca.2008.10.003
21. Hurst RS, Hajós M, Raggenbass M et al (2005) A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J Neurosci 25:4396–4405. doi:10.1523/JNEUROSCI. 5269-04.2005
22. Itier V, Bertrand D (2001) Neuronal nicotinic receptors: from protein structure to function. FEBS Lett 504:118–125
23. Joe Y, Kim HJ, Kim S et al (2011) Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages. J Biol Chem 286:24735–24742. doi:10.1074/jbc.M110.204859
24. Kalamida D, Poulas K, Avramopoulou V et al (2007) Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity. FEBS J 274:3799–3845. doi:10.1111/j.1742-4658.2007.05935.x
25. Karlin A (2002) Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 3:102–114. doi:10.1038/nrn731
26. Karlin A, Akabas MH (1995) Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15:1231–1244
27. Kim T-H, Kim S-J, Lee S-M (2014) Stimulation of the α7 nicotinic acetylcholine receptor protects against sepsis by inhibiting Toll-like receptor via phosphoinositide 3-kinase activation. J Infect Dis 209:1668–1677. doi:10.1093/infdis/jit669
28. Le Novère N, Corringer PJ, Changeux JP (1999) Improved secondary structure predictions for a nicotinic receptor subunit: incorporation of solvent accessibility and experimental data into a two-dimensional representation. Biophys J 76:2329–2345. doi:10.1016/S0006-3495(99)77390-X
29. Le Novère N, Corringer P-J, Changeux J-P (2002) The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol 53:447–456. doi:10.1002/neu.10153
30. Lueders C, Danne O, Müller C et al (2007) Evaluation of a chemiluminescent assay for analysis of choline in human plasma and whole blood. Lab Med 38:726–728. doi:10.1309/1N2NAYWQ53QVR6FX
31. Maldifassi MC, Atienza G, Arnalich F et al (2014) A new IRAK-M-mediated mechanism implicated in the anti-inflammatory effect of nicotine via α7 nicotinic receptors in human macrophages. PLoS ONE 9:e108397. doi:10.1371/journal.pone.0108397
32. Ochoa EL, Chattopadhyay A, McNamee MG (1989) Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators. Cell Mol Neurobiol 9:141–178
33. Papke RL (2014) Merging old and new perspectives on nicotinic acetylcholine receptors. Biochem Pharmacol 89:1–11. doi:10.1016/j.bcp.2014.01.029
34. Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M et al (2008) Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med 14:567–574. doi:10.2119/2008-00079.Parrish
35. Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75–111
36. Paulo JA, Brucker WJ, Hawrot E (2009) Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome. J Proteome Res 8:1849–1858. doi:10.1021/pr800731z
37. Peña G, Cai B, Liu J et al (2010) Unphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis. Eur J Immunol 40:2580–2589. doi:10.1002/eji.201040540
38. Rosas-Ballina M, Olofsson PS, Ochani M et al (2011) Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334:98–101. doi:10.1126/science.1209985
39. Russo P, Taly A (2012) α7-Nicotinic acetylcholine receptors: an old actor for new different roles. Curr Drug Targets 13:574–578
40. Schaal C, Chellappan SP (2014) Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res 12:14–23. doi:10.1158/1541-7786.MCR-13-0541
41. Shen J, Yakel JL (2009) Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol Sin 30:673–680. doi:10.1038/aps.2009.64
42. Skok MV (2009) Editorial: To channel or not to channel? Functioning of nicotinic acetylcholine receptors in leukocytes. J Leukoc Biol 86:1–3. doi:10.1189/JLB.0209106
43. Sundman E, Olofsson PS (2014) Neural control of the immune system. Adv Physiol Educ 38:135–139
44. Tsoyi K, Jang HJ, Kim JW et al (2011) Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine attenuates inflammatory response in macrophages and improves survival in experimental model of sepsis through heme oxygenase-1 induction. Antioxid Redox Signal 14:2057–2070. doi:10.1089/ars.2010.3555
45. Villiger Y, Szanto I, Jaconi S et al (2002) Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes. J Neuroimmunol 126:86–98
46. Wang H, Yu M, Ochani M et al (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384–388. doi:10.1038/nature01339
47. Wang H, Liao H, Ochani M et al (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10:1216–1221. doi:10.1038/nm1124
48. Wang Y, Xiao C, Indersmitten T et al (2014) The duplicated α7 subunits assemble and form functional nicotinic receptors with the full-length α7. J Biol Chem 289:26451–26463. doi:10.1074/jbc.M114.582858
49. Yang J, Liao X, Agarwal MK et al (2007) Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 21:1396–1408. doi:10.1101/gad.1553707
50. Yoshikawa H, Kurokawa M, Ozaki N et al (2006) Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 146:116–123. doi:10.1111/j.1365-2249.2006.03169.x
51. Zhang ZW, Vijayaraghavan S, Berg DK (1994) Neuronal acetylcholine receptors that bind alpha-bungarotoxin with high affinity function as ligand-gated ion channels. Neuron 12:167–177